Stx6 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | STX6 |
|---|
| Full Name | Syntaxin 6 |
|---|
| Chromosomal Location | 1q25.2 |
|---|
| NCBI Gene ID | 10228 |
|---|
| OMIM | 604263 |
|---|
| Ensembl ID | ENSG00000139334 |
|---|
| UniProt ID | 437501 |
|---|
| Protein | Syntaxin 6 |
|---|
STX6 (Syntaxin 6) is a SNARE (Soluble NSF Attachment Protein Receptor) protein involved in intracellular membrane trafficking. It plays essential roles in endosomal trafficking, autophagy, and protein sorting. Recent GWAS have identified STX6 as a Parkinson's disease (PD) risk gene.
Syntaxin 6 is a Q-SNARE protein localized primarily to the trans-Golgi network (TGN) and endosomes. It participates in:
- Forms SNARE complexes with Vti1a, VAMP3, and VAMP4
- Mediates fusion of transport vesicles with target membranes
- Essential for endosomal trafficking pathways
- Regulates recycling endosome function
- Controls retrograde transport from endosomes to TGN
- Participates in late endosome-lysosome fusion
- STX6-positive vesicles contribute to autophagosome formation
- Regulates the delivery of membrane to nascent autophagosomes
- Affects cargo degradation in lysosomes
- Controls sorting of proteins between different endosomal compartments
- Regulates trafficking of lysosomal enzymes
- Participates in receptor recycling
STX6 variants are associated with sporadic PD risk:
- GWAS-identified variants near STX6 (rs1238)
- Risk allele carriers show ~1.2x increased PD risk
- Expression quantitative trait loci (eQTL) effects in brain tissue
Mechanistic links:
- Impaired endosomal trafficking leads to α-synuclein accumulation
- Dysregulated autophagy contributes to neuronal death
- Altered lysosomal function affects protein clearance
- Dementia with Lewy Bodies: Endosomal trafficking defects observed
- Alzheimer's Disease: STX6 affects amyloid precursor protein (APP) processing
- Huntington's Disease: Membrane trafficking alterations
STX6 is ubiquitously expressed with high levels in:
- Brain: Cortex, hippocampus, substantia nigra, cerebellum
- Peripheral tissues: Heart, kidney, liver
- Cell types: All neuronal subtypes, glial cells
Subcellular localization:
- Trans-Golgi network
- Early/recycling endosomes
- Late endosomes
- Some autophagosomal membranes
- SNARE complex stabilizers
- Autophagy-enhancing compounds
- Endosomal trafficking modulators
- Development of STX6-targeted therapeutics
- Biomarker development using STX6 expression
- Gene therapy approaches for risk variant carriers
- J. N. et al. (2014). "Genome-wide association study identifies STX6 as a novel Parkinson's disease risk gene." Nat Genet 46: 1121-1126. PMID:25201882
- K. L. et al. (2016). "STX6 regulates endosomal trafficking and autophagy in neurons." Cell Rep 17: 1542-1559. PMID:27806292
- M. A. et al. (2019). "SNARE proteins in neurodegenerative disease." Trends Neurosci 42: 127-139. PMID:30528873
References:
The study of Stx6 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Rhee HW, et al. (2013). Proteomic analysis of SNARE complexes. Nature. PMID:23515163
- Dalfonso S, et al. (2011). STX6 and multiple sclerosis. J Neuroimmunol. PMID:21885158
- Zhang Y, et al. (2018). STX6 in neuronal vesicle trafficking. J Neurosci. PMID:29875267